Akcea Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch AKCA and buy or sell other stocks, options, and ETFs commission-free!

About AKCA

Akcea Therapeutics is a development and commercialization company focused on helping patients with serious diseases. Our priority is to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize our products on a global basis. 

CEO
Damien McDevitt, PhD
CEODamien McDevitt, PhD
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
Employees

AKCA Key Statistics

Market cap
1.85B
Market cap1.85B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
476.70K
Average volume476.70K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$21.71
52 Week high$21.71
52 Week low
$8.00
52 Week low$8.00

AKCA Earnings

Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.